Three Institutional

3i Group is a leading international investment manager focused on mid-market Private Equity and Infrastructure. While not a biotechnology company itself, 3i is a major player in the healthcare and life sciences sector through its extensive investment portfolio, providing capital and strategic support to companies in medical technology, pharmaceutical services, and healthcare provision. The firm typically targets businesses with enterprise values between €100 million and €500 million, leveraging its global network to drive international growth and operational improvements. Notable healthcare investments have included companies like Hans Anders, Q Holding, and various specialized medical device manufacturers.